• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Absci Corporation - Common Stock (NQ:ABSI)

    8.371 +0.051 (+0.61%)
    Streaming Delayed Price Updated: 1:57 PM EDT, Jul 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 876,617
    Open 8.170
    Bid (Size) 8.370 (100)
    Ask (Size) 8.380 (1,200)
    Prev. Close 8.320
    Today's Range 8.100 - 8.410
    52wk Range 2.240 - 12.05
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
    From Absci Corporation
    Via GlobeNewswire
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill

    Performance

    YTD
    +131.9%
    +131.9%
    1 Month
    -0.3%
    -0.3%
    3 Month
    +114.6%
    +114.6%
    6 Month
    +188.7%
    +188.7%
    1 Year
    +138.5%
    +138.5%

    More News

    Read More
    Here are the top movers in Wednesday's session. ↗
    Via Chartmill
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    Absci Corp (NASDAQ:ABSI) Plunges on 86% Q1 Revenue Miss Despite Clinical Advances ↗
    Via Chartmill
    Absci Corp. (NASDAQ:ABSI) Reports Mixed Q4 Results Amid Clinical Progress ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Wednesday. ↗
    Via Chartmill
    News headline image
    Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    The 1 AI Stock I'd Put in a Time Capsule and Open in 2036 ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Absci to Participate in Upcoming Investor Conferences
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci (ABSI) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci (ABSI) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    Absci to Participate in Upcoming Investor Conferences
    From Absci Corporation
    Via GlobeNewswire
    News headline image
    AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Absci Corporation
    Via GlobeNewswire

    Frequently Asked Questions

    Is Absci Corporation - Common Stock publicly traded?
    Yes, Absci Corporation - Common Stock is publicly traded.
    What exchange does Absci Corporation - Common Stock trade on?
    Absci Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Absci Corporation - Common Stock?
    The ticker symbol for Absci Corporation - Common Stock is ABSI on the Nasdaq Stock Market
    What is the current price of Absci Corporation - Common Stock?
    The current price of Absci Corporation - Common Stock is 8.371
    When was Absci Corporation - Common Stock last traded?
    The last trade of Absci Corporation - Common Stock was at 07/22/26 01:57 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.